Skip to search formSkip to main contentSkip to account menu

SGS742

Known as: SGS-742 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Hippocampal levels of phosphorylated protein kinase a (phosphor‐S96) are linked to spatial memory enhancement by SGS742
Cognitive enhancement by the GABA (B) receptor antagonist SGS742 has been well‐documented, but mechanisms of action are not fully… 
2008
2008
Cognitive enhancement by SGS742 in OF1 mice is linked to specific hippocampal protein expression.
Cognitive enhancement by the GABA (B) antagonist SGS742 has been reported and we decided to search for proteins involved… 
2006
2006
Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons
RationaleAbuse of gamma-hydroxybutyrate (GHB) and its precursors is a public health concern. Gamma-butyrolactone (GBL) is found… 
Review
2005
Review
2005
SGS-742 Novartis.
SGS-742, a GABA(B) antagonist, is being developed by Saegis, under license from Novartis, for the potential treatment of mild… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)